Literature DB >> 12133940

Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: a heterologous bacterial model of attrition.

Dean K Smith1, Renu Dudani, Joao A Pedras-Vasconcelos, Yvan Chapdelaine, Henk van Faassen, Subash Sad.   

Abstract

Induction and maintenance of T cell memory is critical for the control of intracellular pathogens and tumors. Memory T cells seem to require few "maintenance signals," though often such studies are done in the absence of competing immune challenges. Conversely, although attrition of CD8(+) T cell memory has been characterized in heterologous viral models, this is not the case for bacterial infections. In this study, we demonstrate attrition of T cell responses to the intracellular pathogen Listeria monocytogenes (LM) following an immune challenge with a second intracellular bacterium, Mycobacterium bovis (bacillus Calmette-Guérin, BCG). Mice immunized with either LM or recombinant LM (expressing OVA; LM-OVA), develop a potent T cell memory response. This is reflected by peptide-specific CTL, IFN-gamma production, and frequency of IFN-gamma-secreting T cells to native or recombinant LM Ags. However, when the LM-infected mice are subsequently challenged with BCG, there is a marked reduction in the LM-specific T cell responses. These reductions are directly attributable to the effects on CD4(+) and CD8(+) T cells and the data are consistent with a loss of LM-specific T cells, not anergy. Attrition of the Ag (OVA)-specific T cell response is prevented when LM-OVA-immunized mice are challenged with a subsequent heterologous pathogen (BCG) expressing OVA, demonstrating memory T cell dependence on Ag. Although the reduction of the LM-specific T cell response did not impair protection against a subsequent LM rechallenge, for the first time, we show that T cell attrition can result in the reduction of Ag-specific antitumor (B16-OVA) immunity previously established with LM-OVA immunization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133940     DOI: 10.4049/jimmunol.169.3.1197

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Authors:  Jonathan Campbell; Joanne Trgovcich; Michelle Kincaid; Peter D Zimmerman; Paul Klenerman; Stuart Sims; Charles H Cook
Journal:  J Leukoc Biol       Date:  2012-06-22       Impact factor: 4.962

3.  IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium.

Authors:  Renu Dudani; Kaja Murali-Krishna; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

Review 4.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

5.  Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.

Authors:  Rosalind Polley; Stephanie L Sanos; Sara Prickett; Ashraful Haque; Paul M Kaye
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.

Authors:  Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

7.  Attrition of memory CD8 T cells.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nature       Date:  2009-06-04       Impact factor: 49.962

Review 8.  Respiratory infections: do we ever recover?

Authors:  John Goulding; Robert Snelgrove; José Saldana; Arnaud Didierlaurent; Mary Cavanagh; Emily Gwyer; Jeremy Wales; Erika L Wissinger; Tracy Hussell
Journal:  Proc Am Thorac Soc       Date:  2007-12

9.  Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.

Authors:  Katja Nilges; Hanni Höhn; Henryk Pilch; Claudia Neukirch; Kirsten Freitag; P J Talbot; Markus J Maeurer
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Theoretical analysis of the evolution of immune memory.

Authors:  Frederik Graw; Carsten Magnus; Roland R Regoes
Journal:  BMC Evol Biol       Date:  2010-12-08       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.